V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004702 | 290003448 | 1.6 | 43 | Palliative (P) | 2017-08-01 | 2017-08-01 | Cisplatin +Fluorouracil (3 wk) | 1 | N | 290021640 | Y-90 |
| 290004703 | 290006532 | null | 83.2 | Disease modification (D) | 2014-08-30 | 2014-09-30 | Capecitabine 35days + RT | N | N | 290021641 | CISPLATIN + GEMCITABINE |
| 290004704 | 290006532 | null | 88.3 | Palliative (P) | 2013-07-19 | 2013-08-02 | Capecitabine 42days + RT | 02 | N | 290021641 | INTERAACT TRIAL |
| 290004705 | 290003449 | 1.78 | null | Palliative (P) | 2015-10-14 | 2015-10-19 | CAPECITABINE + RT | N | N | 290021645 | CAPECITABINE + TEMOZOLOMIDE |
| 290004706 | 290003450 | 1.61 | null | Adjuvant (A) | null | 2016-03-28 | Rituximab | N | null | 290021649 | LANREOTIDE |
| 290004707 | 290003451 | 0 | 89 | null | 2016-02-02 | 2016-02-05 | CARBOPLATIN + FLUOROURACIL | N | N | 290021654 | CAPECITABINE |
| 290004708 | 290003452 | null | null | Neo-adjuvant (N) | 2015-09-05 | 2015-09-06 | DE-ESCALATE TRIAL | N | N | 290021656 | FLUOROURACIL |
| 290004709 | 290003453 | 1.8 | 73.1 | Adjuvant (A) | 2017-12-11 | 2017-12-16 | Docetaxel | 02 | N | 290021657 | OCTREOTIDE |
| 290004710 | 290006533 | null | 36.35 | Palliative (P) | 2015-01-14 | 2015-06-09 | Dacarbazine | 02 | N | 290021658 | ECX |
| 290004711 | 290003454 | null | 84.9 | Palliative (P) | 2015-11-26 | 2015-11-26 | OCTREOTIDE | 02 | N | 290021659 | CARBOPLATIN + RT |
| 290004712 | 290003455 | 1.55 | null | null | 2017-01-19 | 2017-02-01 | Bortezomib + Cyclophos + Dex | 02 | null | 290021661 | CARBOPLATIN |
| 290004713 | 290003455 | 1.57 | 56.4 | Curative (C) | 2015-01-23 | 2015-02-12 | KESTREL Trial | N | Y | 290021661 | CAPECITABINE |
| 290004714 | 290003456 | 1.84 | 65.4 | Curative (C) | 2013-11-01 | 2013-11-01 | Carboplatin AUC 2 - 5 | 2 | N | 290021663 | EOX |
| 290004715 | 290003457 | 1.67 | 56 | Curative (C) | 2015-10-18 | 2015-11-17 | ECX | 02 | Y | 290021665 | CISPLATIN + FLUOROURACIL |
| 290004716 | 290003458 | null | 55.6 | null | 2016-04-17 | 2016-05-07 | Capecitabine 35days + RT | N | N | 290021670 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004717 | 290003459 | 1.68 | 105.6 | Adjuvant (A) | 2016-10-02 | 2016-10-12 | GEMCITABINE | 2 | null | 290021672 | CAPECITABINE |
| 290004718 | 290003460 | 1.76 | 71.4 | Palliative (P) | 2018-08-04 | 2018-08-04 | LANREOTIDE | 2 | N | 290021673 | CAPECITABINE + STREPTOZOCIN |
| 290004719 | 290003461 | 1.67 | null | Not known (9) | 2017-09-13 | 2017-09-20 | CETUXIMAB | 02 | N | 290021674 | CETUXIMAB + CISPLATIN + FU |
| 290004720 | 290006535 | 1.56 | 72 | Curative (C) | 2017-05-29 | 2017-06-11 | CARBOPLATIN + FLUOROURACIL | N | null | 290021676 | OCTREOTIDE |
| 290004721 | 290006535 | 1.75 | 72.65 | Palliative (P) | 2017-08-27 | 2017-09-03 | MITOMYCIN | N | N | 290021676 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004722 | 290006535 | 1.68 | null | Palliative (P) | 2014-08-26 | 2014-08-26 | Capecitabine | 02 | N | 290021676 | CAPECITABINE + RT |
| 290004723 | 290006535 | 1.58 | 83.3 | Palliative (P) | null | 2017-03-16 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 290021676 | EOX |
| 290004724 | 290003462 | null | null | Curative (C) | 2015-03-18 | 2015-03-31 | BENDAMUSTINE + RITUXIMAB | N | N | 290021682 | OCTREOTIDE |
| 290004725 | 290003462 | 1.79 | 61.7 | Neo-adjuvant (N) | 2013-04-08 | 2013-04-20 | LANREOTIDE | 2 | Y | 290021682 | FLUOROURACIL |
| 290004726 | 290007757 | 1.64 | 72.9 | null | 2016-02-23 | 2016-03-15 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 290021686 | CAPECITABINE |
| 290004727 | 290003463 | 1.47 | 0 | Palliative (P) | 2017-02-26 | 2017-03-19 | Capecitabine | N | N | 290021692 | FLUOROURACIL |
| 290004728 | 290006537 | 1.61 | 110.3 | Palliative (P) | 2013-09-21 | 2013-10-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290021693 | CAPECITABINE + CARBOPLATIN |
| 290004729 | 290003464 | 1.71 | 87.1 | Palliative (P) | 2014-07-14 | 2014-07-16 | Folfirinox | N | N | 290021694 | CARBOPLATIN + ETOPOSIDE |
| 290004731 | 290006538 | 1.6 | 60.4 | Curative (C) | null | 2013-12-07 | Trial Unspecified | N | N | 290021696 | CARBOPLATIN + RT |
| 290004732 | 290006538 | 1.73 | 88 | Palliative (P) | 2016-05-23 | 2016-06-11 | Capecitabine 35days + RT | N | N | 290021696 | CARBOPLATIN |
| 290004733 | 290003466 | 0 | 76.6 | Curative (C) | 2013-08-21 | 2013-09-09 | GEMCITABINE | 01 | Y | 290021699 | CAPECITABINE + RT |
| 290004734 | 290006539 | 1.54 | 81.9 | Curative (C) | 2016-11-17 | 2017-02-16 | Cetuximab +Cisplatin + FU (Cycle 1) | N | Y | 290021700 | Y-90 |
| 290004735 | 290003467 | 1.78 | 76.6 | Disease modification (D) | 2013-03-25 | 2013-04-01 | PLATO Trials | N | N | 290021701 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004736 | 290003467 | null | 55.9 | Adjuvant (A) | 2016-03-13 | 2016-03-14 | OCTREOTIDE | N | N | 290021701 | LANREOTIDE |
| 290004737 | 290003468 | 1.7 | 87.95 | Palliative (P) | 2013-09-10 | 2013-09-30 | ECX | 02 | null | 290021703 | GEMCARBO |
| 290004738 | 290003469 | 1.61 | null | Curative (C) | 2015-07-16 | 2015-08-11 | CETUXIMAB | N | N | 290021705 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 290004739 | 290003470 | 1.77 | 49.9 | Curative (C) | 2014-08-14 | 2014-09-08 | FLUOROURACIL | N | N | 290021707 | CISPLATIN + ETOPOSIDE |
| 290004740 | 290003471 | 1.54 | null | Palliative (P) | 2017-06-03 | 2017-06-03 | Y-90 | null | null | 290021709 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004741 | 290003472 | 1.73 | 69.7 | Palliative (P) | 2015-10-17 | 2015-10-29 | Capecitabine 42days + RT | N | N | 290021710 | CISPLATIN + FLUOROURACIL |
| 290004742 | 290003473 | 0 | null | Palliative (P) | 2013-06-09 | 2013-06-22 | ECX | N | N | 290021716 | CAPECITABINE + RT |
| 290004743 | 290006541 | 1.68 | 86.3 | Palliative (P) | 2017-03-11 | 2017-03-12 | EOX | 02 | null | 290021718 | CARBOPLATIN + CETUXIMAB + FU |
| 290004744 | 290003474 | 1.77 | 61.5 | Curative (C) | 2017-05-10 | 2017-05-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 290021722 | TRIAL |
| 290004745 | 290003475 | 1.77 | 95.3 | Curative (C) | 2016-03-30 | 2016-04-17 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | Y | 290021724 | CARBOPLATIN + ETOPOSIDE |
| 290004746 | 290003476 | 1.74 | 87.5 | Palliative (P) | 2016-12-01 | 2016-12-15 | CARBOPLATIN | N | N | 290021725 | CISPLATIN + FLUOROURACIL |
| 290004747 | 290003476 | null | 95.8 | Palliative (P) | 2015-04-22 | 2015-04-28 | Carboplatin AUC 6 - 10 | N | N | 290021725 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004748 | 290003476 | 1.55 | 52.4 | Adjuvant (A) | null | 2015-01-26 | Melphalan oral | N | N | 290021725 | TRIAL |
| 290004749 | 290003477 | 1.6 | null | Curative (C) | 2016-06-27 | 2016-06-27 | Gemcitabine + Capecitabine | N | N | 290021729 | GEMCARBO |
| 290004750 | 290003478 | 1.6 | null | Palliative (P) | null | 2016-06-17 | Cisplatin + Etoposide po&iv 3 day | N | N | 290021730 | PEMBROLIZUMAB |
| 290004751 | 290003478 | 1.6 | 55.4 | Neo-adjuvant (N) | 2014-05-30 | 2014-05-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 290021730 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290004752 | 290003478 | 1.57 | 42.6 | Palliative (P) | 2016-11-01 | 2016-11-21 | DABRAFENIB + TRAMETINIB | N | N | 290021730 | CARBOPLATIN + ETOPOSIDE |